During the past decade, Private practice conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Private practice" #1 sponsor was "Avigen" with 1 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored, "Pierre Fabre Pharma GmbH" with 1 trials sponsored and "PregLem SA" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Private practice" #1 collaborator was "Pierre Fabre Pharma AG" with 1 trials as a collaborator, "Pierre Fabre Pharma Austria" with 1 trials as a collaborator, "Roche Diabetes Care Deutschland GmbH" with 1 trials as a collaborator and "iOMEDICO AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Private practice" are "Metastatic Colorectal Carcinoma" (1 trials), "Migraine With Aura" (1 trials), "Migraine Without Aura" (1 trials), "Muscle Spasticity" (1 trials) and "Type II Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Private practice" in a lesser frequency.

Most popular intervention types in "Private practice" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Accu-Chek Smart Pix Software" (1 trials), "Accu-Chek Smart Pix readout Device" (1 trials), "Cetuximab" (1 trials), "Eletriptan HBr 40 mg" (1 trials) and "Eletriptan HBr 80 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Private practice" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Private practice". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Private practice, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Private practice, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".